MyFinsight
Home
Blog
About
Net loss
-$16,565K
(70.76%↑ Y/Y)
Other, net
$20,538K
(11384.62%↑ Y/Y)
Interest income
$1,819K
(-5.95%↓ Y/Y)
Loss before income
taxes
-$16,565K
(70.09%↑ Y/Y)
Total other income
(expense), net
$8,849K
(178.69%↑ Y/Y)
Product revenues, net
$18,634K
(3.04%↑ Y/Y)
License revenues and
royalties
$614K
(-18.57%↓ Y/Y)
Interest expense
$13,508K
(3.93%↑ Y/Y)
Loss from operations
-$25,414K
(42.43%↑ Y/Y)
Total revenue, net
$19,248K
(2.17%↑ Y/Y)
Deferred royalty
obligation interest...
$9,125K
(4.61%↑ Y/Y)
Effective interest
expense on senior...
$4,383K
(2.55%↑ Y/Y)
Total operating
expense
$44,662K
(-29.09%↓ Y/Y)
Research and development
$17,366K
(-42.29%↓ Y/Y)
Selling and marketing
$12,572K
(23.90%↑ Y/Y)
General and
administrative
$9,701K
(9.96%↑ Y/Y)
Restructuring and impairment
expenses
$2,674K
(-79.57%↓ Y/Y)
Cost of product sales
$2,349K
(180.98%↑ Y/Y)
Back
Back
Income Statement
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT)
source: myfinsight.com